• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

寻找组胺H3受体拮抗剂的新型先导化合物:胺衍生物。

Search for novel leads for histamine H3-receptor antagonists: amine derivatives.

作者信息

Stark H, Ligneau X, Lipp R, Arrang J M, Schwartz J C, Schunack W

机构信息

Institut für Pharmazie I, Freie Universität Berlin, Germany.

出版信息

Pharmazie. 1997 Jun;52(6):419-23.

PMID:9260265
Abstract

In search for novel leads for histamine H3-receptor antagonists a number of amine derivatives of different (1 H-imidazol-4-yl)anilines and omega-(1 H-imidazol-4-yl)alkanamines were prepared. Pharmacological in vitro H3-receptor investigations of the prepared urea, amide, inverse amide, thioamide, and thiourea derivatives on synaptosomes of rat cerebral cortex proved that the aniline derivatives are inactive at H3-receptors, whereas derivatives of the omega-(1 H-imidazol-4-yl)-alkanamines showed moderate to good activity. Some compounds are active in the nanomolar concentration range. The most potent compounds in this series are the thioamide derivative 7 and the urea derivatives 11, 12 of 3-(1 H-imidazol-4-yl) propanamine. Therefore, the urea derivatives were tested in vitro on isolated organs of the guinea pig for their activity on the other two histamine receptor subtypes proving their high selectivity. In vivo studies of the effects of the urea derivatives 11 and 12 on brain Nt-methylhistamine levels, a test of central H3-receptor activity after peroral application to mice, showed no detectable activity. Thus, the urea type antagonists are useful potent and selective H3-receptor tools for in vitro studies and for investigations of ligand-receptor interactions.

摘要

为了寻找组胺H3受体拮抗剂的新型先导化合物,制备了多种不同的(1H-咪唑-4-基)苯胺和ω-(1H-咪唑-4-基)链烷胺的胺衍生物。对所制备的脲、酰胺、反式酰胺、硫代酰胺和硫脲衍生物在大鼠大脑皮层突触体上进行的体外H3受体药理学研究证明,苯胺衍生物在H3受体上无活性,而ω-(1H-咪唑-4-基)链烷胺的衍生物表现出中等至良好的活性。一些化合物在纳摩尔浓度范围内具有活性。该系列中最有效的化合物是硫代酰胺衍生物7以及3-(1H-咪唑-4-基)丙胺的脲衍生物11、12。因此,对脲衍生物在豚鼠离体器官上进行了体外测试,以检测它们对其他两种组胺受体亚型的活性,结果证明它们具有高选择性。对脲衍生物11和12经口给予小鼠后对脑Nt-甲基组胺水平的影响进行的体内研究,这是一种中枢H3受体活性测试,结果显示未检测到活性。因此,脲型拮抗剂是用于体外研究和配体-受体相互作用研究的有效且选择性的H3受体工具。

相似文献

1
Search for novel leads for histamine H3-receptor antagonists: amine derivatives.寻找组胺H3受体拮抗剂的新型先导化合物:胺衍生物。
Pharmazie. 1997 Jun;52(6):419-23.
2
Search for novel leads for histamine H3-receptor antagonists: oxygen-containing derivatives.寻找组胺H3受体拮抗剂的新型先导化合物:含氧化合物。
Pharmazie. 1997 Jul;52(7):495-500.
3
Development of chiral N-alkylcarbamates as new leads for potent and selective H3-receptor antagonists: synthesis, capillary electrophoresis, and in vitro and oral in vivo activity.手性N-烷基氨基甲酸酯作为强效和选择性H3受体拮抗剂新先导化合物的开发:合成、毛细管电泳以及体外和口服体内活性
J Med Chem. 1999 Feb 25;42(4):593-600. doi: 10.1021/jm9804376.
4
Substituted N-phenylcarbamates as histamine H3 receptor antagonists with improved in vivo potency.作为组胺H3受体拮抗剂的取代N-苯基氨基甲酸酯,其体内效价得到提高。
Pharmazie. 2000 Feb;55(2):83-6.
5
4-Alkynylphenyl imidazolylpropyl ethers as selective histamine H3-receptor antagonists with high oral central nervous system activity.4-炔基苯基咪唑基丙基醚作为具有高口服中枢神经系统活性的选择性组胺H3受体拮抗剂。
J Med Chem. 1998 Oct 8;41(21):4171-6. doi: 10.1021/jm9802970.
6
4-(omega-(alkyloxy)alkyl)-1H-imidazole derivatives as histamine H(3) receptor antagonists/agonists.作为组胺H(3)受体拮抗剂/激动剂的4-(ω-(烷氧基)烷基)-1H-咪唑衍生物
J Med Chem. 2004 May 6;47(10):2678-87. doi: 10.1021/jm031065q.
7
Novel carbamates as potent histamine H3 receptor antagonists with high in vitro and oral in vivo activity.新型氨基甲酸酯类化合物作为强效组胺H3受体拮抗剂,具有高体外活性和口服体内活性。
J Med Chem. 1996 Mar 1;39(5):1157-63. doi: 10.1021/jm9507688.
8
[125I]iodoproxyfan and related compounds: a reversible radioligand and novel classes of antagonists with high affinity and selectivity for the histamine H3 receptor.[125I]碘普罗芬及相关化合物:一种对组胺H3受体具有高亲和力和选择性的可逆放射性配体及新型拮抗剂。
J Med Chem. 1996 Mar 15;39(6):1220-6. doi: 10.1021/jm9504767.
9
Novel nonimidazole histamine H3 receptor antagonists: 1-(4-(phenoxymethyl)benzyl)piperidines and related compounds.新型非咪唑类组胺H3受体拮抗剂:1-(4-(苯氧基甲基)苄基)哌啶及其相关化合物。
J Med Chem. 2003 Apr 10;46(8):1523-30. doi: 10.1021/jm021084k.
10
Synthesis and in vitro pharmacology of a series of new chiral histamine H3-receptor ligands: 2-(R and S)-Amino-3-(1H-imidazol-4(5)-yl)propyl ether derivatives.一系列新型手性组胺H3受体配体的合成及体外药理学研究:2-(R和S)-氨基-3-(1H-咪唑-4(5)-基)丙基醚衍生物
J Med Chem. 1999 Apr 8;42(7):1193-202. doi: 10.1021/jm980408v.